Tags: Anxiety | drug | Vraylar | psychotic

Antipsychotic Drug OKd by FDA

Thursday, 17 September 2015 04:17 PM

Allergan said on Thursday the U.S. Food and Drug Administration approved its new antipsychotic drug to treat bipolar disorder and schizophrenia.

The drug, Vraylar, carries a boxed warning on increased risk of death associated with its use in older people with dementia-related psychosis, the FDA said on its website.

Vraylar was approved after showing efficacy in more than 2,700 adults, the company said.

The new drug will be the second antipsychotic to be sold by Allergan. The company already sells Viibryd to treat major depressive disorder in adults.

Allergan partnered Gedeon Richter to develop Vraylar.

© 2019 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Brain-Health
Allergan said on Thursday the U.S. Food and Drug Administration approved its new antipsychotic drug to treat bipolar disorder and schizophrenia. The drug, Vraylar, carries a boxed warning on increased risk of death associated with its use in older people with...
drug, Vraylar, psychotic
95
2015-17-17
Thursday, 17 September 2015 04:17 PM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved